Publications Maria Ulvmar

Publications in DiVA

Publications in PubMed

Selected publications:

  1. Ulvmar M.H. and Mäkinen T. Heterogeneity in the lymphatic vascular system and its origin (2016) Cardiovascular Research, 111(4): 310-321.
  2. Ulvmar M.H., Martínez-Corral I., Stanczuk L.; Mäkinen T. Pdgfrb-Cre targets lymphatic endothelial cells of both venous and non-venous origins. (2016) Genesis, 54(6), 350-358.
  3. Martínez-Corral I., Stanczuk L.; Frye M., Ulvmar M.; Dieguez-Hurtado R., Olmeda D., Mäkinen T. and Ortega S. Vegfr3-CreERT2 mouse, a new genetic tool for targeting the lymphatic system.(2016) Angiogenesis, 19(3), 433-445.
  4. Lucas B., White A.J., Ulvmar M.H., Nibbs R.J., Sitnik K.M., Agace W.W., Anderson G., Rot A. The atypical chemokine receptor CCRL1/ACKR4 is expressed in key thymic microenvironments but is dispensable for T lymphopoiesis at steady state in adult mice. (2015) European Journal of Immunology, 45(2); 574-583.
  5. Martinez-Corral I., Ulvmar M.H., Stanczuk L., Tatin F., Kizhatil K., John S.W., Alitalo K., Ortega S. and Makinen T. Non-venous origin of the dermal lymphatic vasculature. (2015) Circulation Research, 16(10), 1649-54.
  6. Stanczuk L., Martinez-Corral I., Ulvmar M.H., Zhang Y., Siemsen B.L., Fruttiger M., Adams R.H., Sauer D., Betsholtz C., Ortega S., Alitalo K., Graupera M. and Makinen T. cKit Lineage Hemogenic Endothelium-Derived Cells Contribute to Mesenteric Lymphatic Vessels. (2015) Cell Reports, 10(10), 1708-1721.
  7. Ulvmar M.H*., Werth K.*, Braun A., Kelay P., Hub E., Eller K., Chan L., Lucas B., Novitzky-Basso I., Nakamura K., Rülicke T., Nibbs R.J., Worbs T., Förster R., Rot A. The atypical chemokine receptor CCRL1 shapes functional CCL21 gradients in lymph nodes. (2014) Nature Immunology, 15(7); 623-630. Selected for cover artwork.
  8. Kumari S*.; Bonnet M*.; Ulvmar M.H*., Karagianni N.; Uthoff-Hachenberg C., Sabat R.; Kollias G.; Toftgård R.; Haase I. and Pasparakis M. TNFR1 signaling in NF-kB-deficient keratinocytes triggers IL-24-dependent psoriasis like skin inflammation in mice. (2013) Immunity, 39(5): 899-911.
  9. Ulvmar M.H., Sur I., Memet S., Toftgård R. Timed NF-kappaB inhibition in skin reveals dual independent effects on development of HED/EDA and chronic inflammation. (2009) Journal of Investigative Dermatology, 129(11): 2584-93.
  10. Lind (Ulvmar) M.H., Rozell B., Wallin R.P., van Hogerlinden M., Ljunggren H.G., Toftgård R., Sur I. Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-kappaB inhibition. (2004) Proceedings of the National Academy of Science United States of America (PNAS) 101(14): 4972-7.

    * shared first authors